Format

Send to

Choose Destination
Value Health. 2015 Nov;18(7):A611-2. doi: 10.1016/j.jval.2015.09.2121. Epub 2015 Oct 20.

Basal Insulin Persistence, Associated Factors, and Outcomes After Treatment Initiation Among People With Type 2 Diabetes Mellitus In Japan.

Author information

1
Lilly Deutschland GmbH, Bad Homburg, Germany.
2
Analysis Group, Inc., Boston, MA, USA.
3
Analysis Group, Inc., New York, NY, USA.
4
Eli Lilly Japan KK, Kobe, Japan.
5
Eli Lilly and Company, Indianapolis, IN, USA.
6
Eli Lilly and Company Limited, Windlesham, Surrey, UK.
PMID:
26533432
DOI:
10.1016/j.jval.2015.09.2121
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center